Ekta Kapoor1, Madison Okuno2, Virginia M Miller3, Liliana Gazzuola Rocca4, Walter A Rocca5, Juliana M Kling6, Carol L Kuhle7, Kristin C Mara8, Felicity T Enders8, Stephanie S Faubion9. 1. Center for Women's Health, Mayo Clinic, 200 First St SW, Rochester, MN, USA; Division of General Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, USA; Division of Endocrinology, Diabetes, Metabolism, & Nutrition, Mayo Clinic, 200 First St SW, Rochester, MN, USA. Electronic address: Kapoor.ekta@mayo.edu. 2. University of Minnesota Medical School, 420 Delaware St SE, Minneapolis, MN, USA. 3. Departments of Surgery and Physiology and Biomedical Engineering, Mayo Clinic, 200 First St SW, Rochester, MN, USA. 4. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, MN, USA. 5. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, MN, USA; Women's Health Research Center, Mayo Clinic, 200 First St SW, Rochester, MN, USA; Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN, USA. 6. Division of Women's Health Internal Medicine, Mayo Clinic, Scottsdale, AZ, USA. 7. Center for Women's Health, Mayo Clinic, 200 First St SW, Rochester, MN, USA; Division of General Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, USA. 8. Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First St SW, Rochester, MN, USA. 9. Center for Women's Health, Mayo Clinic, 200 First St SW, Rochester, MN, USA; Division of General Internal Medicine, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, USA.
Abstract
OBJECTIVE: To examine the association of adverse childhood experiences (ACEs) with overall menopausal symptom burden in midlife women. STUDY DESIGN: This was a cross-sectional study of women between the ages of 40 and 65 years who were seen for specialty consultation in the Menopause and Women's Sexual Health Clinic, Mayo Clinic, Rochester, MN between May 1, 2015 and December 31, 2016. MAIN OUTCOME MEASURES: Participants completed the ACE questionnaire to assess childhood abuse and neglect, the Menopause Rating Scale (MRS) to assess menopausal symptom burden, the Patient Health Questionnaire (PHQ-9) to assess depression, the Generalized Anxiety Disorder questionnaire (GAD-7) to assess anxiety, and provided information on current abuse (physical, sexual and verbal/emotional). RESULTS: Women meeting inclusion criteria (N = 1670) had a median age of 53.7 years (interquartile range: 49.1, 58.0). Of these women, 977 (58.5 %) reported any ACE and 288 (17.2 %) reported ≥4 ACEs. As menopausal symptoms increased in severity from the first to fourth quartile, the odds ratio of ACE 1-3 (vs. 0) increased from 1 to 2.50 (trend p < 0.01), and the odds ratio of ACE ≥ 4 (vs. 0) increased from 1 to 9.61 (trend p < 0.01), a pattern that was consistent across all menopausal symptom domains. The association between severe menopausal symptoms and higher childhood adversity (ACE score 1-3 or ≥4 vs. ACE = 0) remained significant after adjusting for age, partner status, education, employment, depression, anxiety, and hormone therapy use (OR 1.84 and 4.51, p < 0.01). CONCLUSION: In this large cross-sectional study, there was a significant association between childhood adversity and self-reported menopausal symptoms that persisted even after adjustment for multiple confounders. These associations highlight the importance of screening women with bothersome menopausal symptoms for childhood adversity, and of offering appropriate management and counseling for the adverse experiences, when indicated.
OBJECTIVE: To examine the association of adverse childhood experiences (ACEs) with overall menopausal symptom burden in midlife women. STUDY DESIGN: This was a cross-sectional study of women between the ages of 40 and 65 years who were seen for specialty consultation in the Menopause and Women's Sexual Health Clinic, Mayo Clinic, Rochester, MN between May 1, 2015 and December 31, 2016. MAIN OUTCOME MEASURES: Participants completed the ACE questionnaire to assess childhood abuse and neglect, the Menopause Rating Scale (MRS) to assess menopausal symptom burden, the Patient Health Questionnaire (PHQ-9) to assess depression, the Generalized Anxiety Disorder questionnaire (GAD-7) to assess anxiety, and provided information on current abuse (physical, sexual and verbal/emotional). RESULTS: Women meeting inclusion criteria (N = 1670) had a median age of 53.7 years (interquartile range: 49.1, 58.0). Of these women, 977 (58.5 %) reported any ACE and 288 (17.2 %) reported ≥4 ACEs. As menopausal symptoms increased in severity from the first to fourth quartile, the odds ratio of ACE 1-3 (vs. 0) increased from 1 to 2.50 (trend p < 0.01), and the odds ratio of ACE ≥ 4 (vs. 0) increased from 1 to 9.61 (trend p < 0.01), a pattern that was consistent across all menopausal symptom domains. The association between severe menopausal symptoms and higher childhood adversity (ACE score 1-3 or ≥4 vs. ACE = 0) remained significant after adjusting for age, partner status, education, employment, depression, anxiety, and hormone therapy use (OR 1.84 and 4.51, p < 0.01). CONCLUSION: In this large cross-sectional study, there was a significant association between childhood adversity and self-reported menopausal symptoms that persisted even after adjustment for multiple confounders. These associations highlight the importance of screening women with bothersome menopausal symptoms for childhood adversity, and of offering appropriate management and counseling for the adverse experiences, when indicated.
Authors: Robert F Anda; Vincent J Felitti; J Douglas Bremner; John D Walker; Charles Whitfield; Bruce D Perry; Shanta R Dube; Wayne H Giles Journal: Eur Arch Psychiatry Clin Neurosci Date: 2005-11-29 Impact factor: 5.270
Authors: Suneela Vegunta; Carol Kuhle; Juliana M Kling; Julia A Files; Ekta Kapoor; Paru S David; Jordan Rullo; Richa Sood; Jacqueline M Thielen; Aminah Jatoi; Darrell R Schroeder; Stephanie S Faubion Journal: Menopause Date: 2016-05 Impact factor: 2.953
Authors: Sheila Shanmugan; James Loughead; Wen Cao; Mary D Sammel; Theodore D Satterthwaite; Kosha Ruparel; Ruben C Gur; C Neill Epperson Journal: Neuropsychopharmacology Date: 2017-03-21 Impact factor: 7.853
Authors: Bernd Löwe; Oliver Decker; Stefanie Müller; Elmar Brähler; Dieter Schellberg; Wolfgang Herzog; Philipp Yorck Herzberg Journal: Med Care Date: 2008-03 Impact factor: 2.983
Authors: Rebecca C Thurston; MaryFran R Sowers; Kim Sutton-Tyrrell; Susan A Everson-Rose; Tené T Lewis; Daniel Edmundowicz; Karen A Matthews Journal: Menopause Date: 2008 May-Jun Impact factor: 2.953
Authors: Leah K Gilbert; Matthew J Breiding; Melissa T Merrick; William W Thompson; Derek C Ford; Satvinder S Dhingra; Sharyn E Parks Journal: Am J Prev Med Date: 2014-10-06 Impact factor: 5.043
Authors: Liliana Gazzuola Rocca; Carin Y Smith; Brandon R Grossardt; Stephanie S Faubion; Lynne T Shuster; Elizabeth A Stewart; Walter A Rocca Journal: BMJ Open Date: 2017-06-07 Impact factor: 2.692
Authors: Monique J Brown; Amandeep Kaur; Titilayo James; Carlos Avalos; Prince N O Addo; Elizabeth Crouch; Nikki L Hill Journal: J Appl Gerontol Date: 2021-12-13